Delivery Order SPE2DB20D3505-SPE2DB22FT8R2
Award Date
6/1/22
Potential Completion Date
6/2/22
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,485.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, with a completion date of September 20, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated with any set-aside requirements, indicating full and open competition. Amerisourcebergen Drug...
This federal contract award, valued at $2,693.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XCOPRI 200 mg tablets, a prescription medication, to support military and veterans' healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,170.64 firm fixed-price delivery order is for the pharmaceutical product XCOPRI 200 MG TABLET 30S, and has an ultimate completion date of May 3, 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to...
This federal contract award, identified as SPE2DB20D3505|SPE2DB24FT4C2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,375.56 delivery order contract is for the supply of the pharmaceutical product XCOPRI 100 MG TABLET 30S. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that runs through December 1, 2023. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,899.54 delivery order contract is for the delivery of the pharmaceutical product XCOPRI 100 MG TABLET 30S. The contract has a period of performance through May 1, 2024 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support...
This federal contract award, SPE2DX15D3013|SPE2DX24FH0H5, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The contract is for the delivery of XCOPRI 200 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,692.07 and a completion date of December 8, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,433.68 firm fixed-price delivery order contract is for the supply of XCOPRI 100 MG TABLET 30S, a type of pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,292.56 firm-fixed-price delivery order is for the supply of Xcopri 100 mg tablets, a medication used in the treatment of epilepsy. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of Xcopri 50 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,247.98, was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for a period ending on August 21, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a total potential value of up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,167.98 firm fixed-price delivery order is for the pharmaceutical product XCOPRI 50 MG TABLET 30S, with a completion date of January 12, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November...